NCT04484337 · Interventional trial
Study to Evaluate Pharmacokinetic (PK), Safety and Tolerability of Cabotegravir (CAB) 400 Milligrams Per Milliliter (mg/mL) Formulation in Healthy Adult Participants
Overall registry status Completed
Phase 1
Conditions HIV Infections
Delaware Valley sites
- GSK Investigational Site · Berlin, NJ · Camden County
First posted
Registry updated
Added to the directory